[
    [
        {
            "time": "",
            "original_text": "上海医药非公开发行引入战投云南白药 发力医药工业与医药商业双赛道",
            "features": {
                "keywords": [
                    "上海医药",
                    "非公开发行",
                    "战投",
                    "云南白药",
                    "医药工业",
                    "医药商业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海医药非公开发行引入战投云南白药 发力医药工业与医药商业双赛道",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上海医药：公司收购的是芬兰口腔医疗公司菲曼特100%股权，收购完成后合资公司上海菲曼特也将成为公司子公司",
            "features": {
                "keywords": [
                    "上海医药",
                    "收购",
                    "芬兰",
                    "口腔医疗",
                    "菲曼特",
                    "股权"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "口腔医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海医药：公司收购的是芬兰口腔医疗公司菲曼特100%股权，收购完成后合资公司上海菲曼特也将成为公司子公司",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "评级机构警告：有些制药企业在大流行机会前 有点丢制药业的脸",
            "features": {
                "keywords": [
                    "评级机构",
                    "警告",
                    "制药企业",
                    "大流行",
                    "机会"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "评级机构警告：有些制药企业在大流行机会前 有点丢制药业的脸",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]